Active Ingredient History

  • Now
Solabegron is a drug which acts as a selective agonist for the β3 adrenergic receptor. It is being developed for the treatment of overactive bladder and irritable bowel syndrome. It has been shown to produce visceral analgesia by releasing somatostatin from adipocytes.   Wikipedia

  • SMILES: O[C@@H](CNCCNc1cccc(c1)c2cccc(c2)C(=O)O)c3cccc(Cl)c3
  • Mol. Mass: 410.9
  • ALogP: 4.44
  • ChEMBL Molecule:
More Chemistry
3'-((2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1'-biphenyl)-3-carboxylic acid | gw427353 | gw 427353 | gw-427353 | (r)-3'-((2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1'-biphenyl)-3-carboxylic acid | solabegron | solabegron hydrochloride


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue